Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc.（ACXP）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
acxp · 股价预测 · 3 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 3 位华尔街分析师
Buy
3 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $1.62
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.54 | ↓ 5.00% |
1-day model range: $1.51–$1.57. Peak: $1.57 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · ACXP · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-09-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-12-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-03-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Acurx Pharmaceuticals, Inc. (ACXP) stock. Of the recent 22 rating actions, 0 were upgrades and 0 were downgrades. 3 analysts currently cover ACXP.
分析师推荐趋势
ACXP analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 98.9% YoY
Revenue Next Year
$4M
↑ 1180.8% YoY
EPS This Year
$-1.65
EPS Next Year
$-1.77
↑ 6.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast ACXP EPS of $-1.65 for the current fiscal year, based on estimates from 1 analysts. The ACXP revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ACXP 股价预测由两类独立数据源支撑：来自 3 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ACXP 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
ACXP 的短期预测（明日）为 $1.54（-5.00%）。
Acurx Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 ACXP。ACXP 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
ACXP 预测 · 8 个问题根据 3 位华尔街分析师，ACXP 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $1.62，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.